WFUMB Guidelines and Recommendations for Clinical Use of Ultrasound Elastography: Part 2: Breast  by Barr, Richard G. et al.
Ultrasound in Med. & Biol., Vol. 41, No. 5, pp. 1148–1160, 2015
 2015 Published by Elsevier Inc. on behalf of World Federation for Ultrasound in Medicine & Biology
Printed in the USA. All rights reserved
0301-5629/$ - see front matter
/j.ultrasmedbio.2015.03.008http://dx.doi.org/10.1016Rad
725
330WFUMB GUIDELINES AND RECOMMENDATIONS FOR CLINICAL USE OF
ULTRASOUND ELASTOGRAPHY: PART 2: BREAST
RICHARD G. BARR, MD, PHD,1 KAZUTAKA NAKASHIMA, MD, PHD,2 DOMINIQUE AMY, MD,3
DAVID COSGROVE, MD,4 ANDRE FARROKH, MD,5 FRITZ SCHAFER, MD,6 JEFFREY C. BAMBER, PHD,7
LAURENT CASTERA, MD,8 BYUNG IHN CHOI, MD,9 YI-HONG CHOU, MD,10
CHRISTOPH F. DIETRICH, MD, PHD,11 HONG DING, MD,12 GIOVANNA FERRAIOLI, MD,13
CARLO FILICE, MD,13 MIREEN FRIEDRICH-RUST, MD,14 TIMOTHY J. HALL, PHD,15
KATHRYN R. NIGHTINGALE, PHD,16 MARK L. PALMERI, MD, PHD,16 TSUYOSHI SHIINA, PHD,17
SHINICHI SUZUKI, MD,18 IOAN SPOREA, MD, PHD,19 STEPHANIE WILSON, MD,20
and MASATOSHI KUDO, MD, PHD21
1)Department of Radiology, Northeastern Ohio Medical University, Rootstown, Ohio and Radiology Consultants Inc.,
Youngstown, Ohio, USA; 2)Department of General Surgery, Kawasaki Medical School, Okayama, Japan; 3)Breast Center,
21 ave V.Hugo 13100 Aix-en-Provence, France; 4) Imaging Departments, Imperial and Kings Colleges, London, United
Kingdom; 5)Department of Gynecology and Obstetrics, Franziskus Hospital Bielefeld, Germany; 6)Department of Breast
Imaging and Interventions, University Hospital Schleswig-Holstein Campus Kiel, Germany; 7) Joint Department of Physics,
Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK; 8)Service d’Hepatologie, Ho^pital
Beaujon, Clichy, Assistance Publique-Ho^pitaux de Paris, INSERM U 773 CRB3, Universite Denis Diderot Paris-VII, France;
9)Department of Radiology, Seoul National University Hospital, Seoul, Korea; 10)Department of Radiology, Veterans General
Hospital and National Yang-Ming University, School of Medicine, Taipei; 11)Medizinische Klinik 2, Caritas-Krankenhaus Bad
Mergentheim, Germany; 12)Department of Ultrasound, Zhongshan Hospital, Fudan University, China; 13)Ultrasound Unit -
Infectious Diseases Department, Fondazione IRCCS Policlinico San Matteo - University of Pavia, Italy; 14)Department of
Internal Medicine 1, J. W. Goethe University Hospital, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany;
15)Department of Medical Physics, University of Wisconsin-Madison, Madison, WI, USA; 16)Department of Biomedical
Engineering, Duke University, Durham, NC, USA; 17)Department of Human Health Sciences, Graduate School of Medicine,
Kyoto University, Kyoto, Japan; 18)Department of Thyroid and Endocrinology, Fukushima Medical University, School of
Medicine, Fukushima, Japan; 19)Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy
Timis¸oara, Romania; 20)Department of Diagnostic Imaging, Foothills Medical Centre, University of Calgary, Calgary, AB,
Canada; and 21)Department of Gastroenterology and Hepatology, Kinki University School of Medicine, Osaka-Sayama,
Osaka, Japan
Abstract—The breast section of these Guidelines and Recommendations for Elastography produced under the
auspices of the World Federation of Ultrasound in Medicine and Biology (WFUMB) assesses the clinically used
applications of all forms of elastography used in breast imaging. The literature on various breast elastography
techniques is reviewed, and recommendations are made on evidence-based results. Practical advice is given on
how to perform and interpret breast elastography for optimal results, with emphasis placed on avoiding pitfalls.
Artifacts are reviewed, and the clinical utility of some artifacts is discussed. Both strain and shear wave techniques
have been shown to be highly accurate in characterizing breast lesions as benign or malignant. The relationship
between the various techniques is discussed, and recommended interpretation based on a BI-RADS-like malig-
nancy probability scale is provided. This document is intended to be used as a reference and to guide clinical users
in a practical way. (E-mail: rgbarr@zoominternet.net)  2015 Published by Elsevier Inc. on behalf of World
Federation for Ultrasound in Medicine & Biology.
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Elastography is the most noteworthy of the new technol-
ogies in recent diagnostic ultrasound systems. Cancer tis-
sue is stiffer than normal breast tissue, and it is believedCorresponding author: Dr. Richard G. BarrMD, PhD, Professor of
iology, Northeastern Ohio Medical College, Southwoods Imaging,
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1148that the stiffening process begins in the early stage of can-
cer. The idea of using this stiffness information for diag-
nosis evolved into a new diagnostic imaging method for
detecting tissue elasticity (stiffness) and evaluating it
noninvasively and objectively using ultrasound.
Initially introduced in 2003, elastography technol-
ogy has since improved together with advances in diag-
nostic ultrasound systems; some form of elastography is
available on most commercially available ultrasound
WFUMB Guidelines for Ultrasound Elastography - Breast d R. G. BARR et al. 1149systems today. Current elastography systems can not only
differentiate between benign andmalignant tissue but also
evaluate histological information by depicting the distri-
bution of tissue stiffness, which may have the potential
to evaluate the therapeutic effect of treatment with anti-
cancer agents. Elastography allows for diagnosis and eval-
uation not only of masses but also of non-mass lesions.
More recently, systems equipped with various
methods that apply strain have become available. They
include systems with strain elastography (SE), which re-
quires manual compression vibration, and systems equip-
ped shear wave elastography (SWE) technology that
supply vibration energy by means of ultrasound. These
methods share the concept of bringing qualitative diag-
nostic capability, i.e., imaging and numerical expression
of the stiffness of a target, into the field of ultrasonogra-
phy, which is primarily concerned with morphological
diagnosis. However, these methods differ in terms of their
theory, the direction of their development, and their accu-
racy. Moreover, there are various methods and terms
related to diagnostic assessment, such as elasticity scores
(Tsukuba score, strain pattern), E/B ratio (width ratio,
length ratio), strain ratio (fat-lesion ratio (LFR)), and
shear wave measurements (kPa, and m/s), which often
lead to confusion when initially using elastography.
Guidelines have been proposed by EFSUMB
(Cosgrove, Piscaglia et al. 2013) and JSUM (Nakashima
et al 2013).
The WFUMB Guidelines and Clinical Practice Recom-
mendations for Elastography of Breast advocate an elas-
tography classification table (Table 1) to help organize
and understand the wide variety of elastographic
methods. This report describes this classification and pre-
sents and explains the evidence for elastography, its clin-
ical utility, the characteristics of each method, clinical
images, etc.CLASSIFICATION OF ELASTOGRAPHY
Classification by technical method
The WFUMB Expert Members for Elastography
Consensus Guideline advocated the following classifica-
tion (Table 1).
In this table, the applied stress is classified (columns)
into Manual Force (achieved by vibration caused by
manual compression or involuntary movement of arm
muscles, etc., or vibration caused by the patient’smuscular
contraction or breathing, etc.) and Acoustic Force
(achieved by ultrasound irradiation force from a probe),
while imaging information is classified (rows) into strain
imaging, which is calculated based on (relative) displace-
ment, and shear wave imaging, which is calculated based
on the propagation speed of shear waves. In actual clinical
practice, shear wave imaging using manual compressionfor applying vibration/compression is not used for breast
imaging, so elastographic techniques can be classified
into the following three groups.
 Strain Imaging: Esaote, GE, Hitachi-Aloka, Medison
Samsung, Philips, Siemens, Toshiba,Ultrasonix, Zonare
 ARFI displacement: Siemens
 SWSMeasurement and Imaging: Siemens, SuperSonic
Imagine
Classification by interpretation
Three main diagnostic methods are used to classify
lesions based on reported evidence and similar findings
from clinical investigations and based on the manu-
facturer’s recommended method in the absence of such
reports. Each has its advantages and disadvantages, and
not all are supported by good evidence. A detailed expla-
nation of each unit will be given in the latter half of this
report.
 Pattern diagnosis is based on color or grayscale elas-
tography images, and a diagnosis is made based on
the assessed score.
Terminology: Tsukuba score (Elasticity Score,
Strain Pattern)
 Grayscale images from elastography are compared
with B-mode images, and a diagnosis is made based
on the size ratio of the target lesion.
Terminology: EI/B ratio, width ratio, length ratio
 Diagnosis is made by assigning a relative numerical
value to the stiffness (tissue elasticity)
Terminology: Strain ratio (fat-lesion ratio (FLR)),
kPa (unit of stiffness), m/s
a. Strain ratio (fat-lesion ratio (FLR)) Semi-quantitative
method for numerically evaluating how many times
stiffer a target mass is compared to subcutaneous fat
by SE.
b. kPa (unit of stiffness), m/s (unit of SWS): quantitative
values calculated for the SWS determined by stiffness
in Shear Wave Elastography system.PROCEDURES (TIPS AND TRICKS)
How to obtain a good elastography
Be mindful of the following 3 points when gener-
ating images.
Obtain a good B-mode image to get a good elastog-
raphy image!. Elastography images are often generated
based on raw data from B-mode images, and many
methods require good B-mode images to succeed. The
examiner should switch to elastography after first ascer-
taining that the B-mode images are optimal.
Table 1. Information on the classification of ultrasound elastography. Different methods for the applied stress and imaging
information are organized into columns and rows, respectively.
Measured physical quantity
Strain or Displacement  Shear wave speed 
V
Excitation methods
Strain imaging Shear wave imaging
(A) Manual compression
- Palpation,
- Cardiovascular 
pulsation
- Respiration
Strain elastography N/A
ElaXtoTM
Real-time tissue elastographyTM
Elastography
ElastoScanTM
eSieTouchTM Elasticity Imaging
Esaote
Hitachi Aloka
GE, 
Philips,Toshiba
Ultrasonix,
Mindray
Samsung
Siemens
(B) Acoustic radiation force 
impulse excitation *ARFI Imaging
**Point shear wave speed measurement 
(Average shear wave speed in a region of interest)
VirtualTouchTM
Imaging (VTI /ARFI)
Siemens Virtual TouchTM
Quantification (VTQ/ARFI) 
ElastPQTM
Siemens 
Philips
Shear wave speed imaging
ShearWaveTM Elastography: (SWETM)
Virtual TouchTM Image 
Quantification (VTIQ/ARFI)
SuperSonic-
Imagine 
Siemens
(C) Controlled external 
vibration
***Transient elastography
(Point shear wave speed measurement)
FibroScanTM Echosens
Methods
Excitation method
Strain imaging Shear wave imaging  
(A) Manual compression
Palpation,
Cardiovascular pulsation
Respiratory 
Strain elastography 
Strain or normalized strain
Geometric measures
Strain ratio
E/B size ratio
(B) Acoustic radiation
force impulse excitation
ARFI Imaging Point shear wave speed measurement 
Displacement or normalized displacement
Geometric measures
Displacement ratio
E/B size ratio
Shear wave speed (m/s) 
Young’s modulus (kPa)
Shear wave speed imaging 
Shear wave speed (m/s)
Young’s modulus (kPa)
(C) Mechanical external 
vibration
Transient Elastography
Young’s modulus (kPa)
Methods
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skin.. Both manual compression and acoustic radiation
force are meaningless if the probe moves across the target
and this will occur with even slight changes in the probe
angle, so it is of paramount importance to ensure that the
probe remains perpendicular to the skin. Therefore, it is
important to ensure that you find a position that allows
for stable vibration, compression, and minimal patient
motion (see WFUMB website for examples).
For Strain Imaging, know the best maneuver for
each system and target.. There are three main types of
compression or vibration methods: ‘‘no manual compres-
sion,’’ ‘‘minimal vibration,’’ and ‘‘significant compres-
sion’’; video clips of each technique are available
online (2013). It is not necessary to generate much vibra-
tion when imaging shallow lesions, but greater vibration
is needed for deep lesions (Table.1).
 No Manual Compression
Place the probe vertically on the skin without
consciously applying any vibration/compression. Keep
the probe lightly touching the skin and try not to apply
pressure (Barr and Zhang 2012). It is important to keep
your hands vertical with no pressure (minimal pre-
compression) and still on the skin above a target (Barr
and Zhang 2012).
Here the minimal vibration energy of the operator
and patient is exploited, so images with good spatial reso-
lution are possible. However, in some cases (large breasts
or deep lesions) minimal vibration may be required.
 Minimal vibration
Place the probe vertically on the skin and apply
very mild vibration. Do not push too hard. The vibration
stroke should be no more than 1 mm. Keep the probe
lightly touching the skin, and apply extremely fine vi-
bration with a few cycles/second, as if lifting up the
skin with the probe, likening the coupling gel to glue.
Vibration should be applied as if you are not moving
your hand at all when you observe it. This method
can be used for relatively shallow lesions to moderately1 2 3 4
Figure 1. Graphic depiction of the Tsukuba score (Elasticity sc
ratio changes and degree of stiffness of the lesion. If the lesion
mixed pattern, it is given a score of 2. A lesion that is hard but
lesion is hard and the same size on elastography as in B-mode
larger on elastography the lesion is classified as 5. It is recomm
Ueno et al. 2006). Scores of 1 to 3 are classified as probably beni
appearance of blue, green, and red (BGR) isdeep lesions, and it allows elastography imaging of
small targets several millimeters in size such as non-
mass abnormalities. It can depict the distribution of
soft areas (areas with significant strain), and it provides
useful diagnostic information (see WFUMB website for
examples)
 Significant compression
Place the probe vertically on the skin, and apply
fairly significant compression/release (approximately
1-2 mm). This method is similar to the dynamic test in
B-mode imaging. As long as the tumor is fairly large,
adequate elastography images of lesions at most depths
can be obtained (see WFUMB website for examples).
 Results and Limitations
Strain
Diagnostic approach and evidence. Some reports
suggest the utility of strain imaging is to up-grade or
down-grade a lesion ultrasound BI-RADS classifica-
tion of a lesion (Chiorean 2008, Tan, Teh et al.
2008). Other reports suggest elastography can not
only be used to differentiate benign and malignant tu-
mors, but can be effective for evaluation of therapy
and for lesions that do form a mass (Nakashima and
Moriya 2012)
Utility for differentiating benign and malignant
masses. The Tsukuba score (Itoh, Ueno et al. 2006) (Elas-
ticity score), EI/B mode ratio and strain ratio (FLR) have
been proposed for characterizing breast masses as benign
or malignant (Ueno E 2007).
 Tsukuba score (Elasticity score)
The Tsukuba score (Figure 1) is a five-point scale
that visually grades the stiffness of a mass. Its sensitivity,
specificity, and accuracy for differentiating between
benign and malignant breast masses were reported to be
86.5%, 89.9%, and 88.3% (Itoh, Ueno et al. 2006),
respectively. A score from 1 to 5 is assigned based on
the color (balance of green and blue) inside the tumor5 BGR
ore) (Itoh, Ueno et al. 2006). This scale combines the size
is soft, it is classified as a score of 1; if the lesion has a
smaller on the elastogram is given a score of 3. When the
, the lesion is given a score of 4. If the lesion is hard and
ended that lesions with scores of 4 or 5 be biopsied (Itoh,
gn.With some equipment (Hitachi, Toshiba) a tri-laminar
identified in cysts (tri-color artifact).
Figure 2. A 45-year-old woman presenting with an abnormality
in her right breast on screening mammography. In this Philips
image, the SE is present on the right and the B-mode image is
presented on the left. By measuring the lesion on the SE image
and the B-mode image, the system calculates the EI/B ratio. In
this case, the EI/B ratio is 1.94, suggesting a malignant lesion.
The final diagnosis is invasive ductal carcinoma.
1152 Ultrasound in Medicine and Biology Volume 41, Number 5, 2015and the surrounding area, with a higher score indicating a
higher diagnostic confidence of malignancy.
Raza S et al.(Raza, Odulate et al. 2010) reported a
prospective clinical study using Ito et al.’s elasticity
score, and they reported a sensitivity of 92.7% and a spec-
ificity of 85.8%.
A ROI that includes various tissue types (fat, fibro-
glandular tissue, pectorals muscle) in which the lesion
accounts for no more than ¼ of the ROI should be chosen.
Limitations include the fact that judgment is subjective
and that it cannot be used for large tumors because the
tumor and the surrounding tissue affect assessment.
Chang JM et al. (Chang, Moon et al. 2011) analyzed
factors that affect the accuracy of elasticity scores in a
prospective study and determined that the accuracy of
elastography differed depending on the depth of the
lesion and that accuracy control was necessary.Figure 3. A 69-year-old woman presenting with a 6-mmmass o
the right side of the image while the B-mode image is on the lef
in a region of fat. The system calculated the lesion to fat ratio (LF
suggestive of malignancy. The mass was diagnosed as an invasiv
needle bio EI/B ratio, width ratio, length ratio
Using a real-time dual SE system, Hall (Hall, Zhu
et al. 2003) demonstrated that benign lesions are smaller
than the corresponding B-mode image while malignant le-
sions are larger (Figure 2). They proposed utilizing the ra-
tio of the lesion size on elastography to the B-mode size
(EI/B-mode ratio) as a diagnostic criterion for benign or
malignant. Barr (Barr 2010) in a single center un-blinded
trial of 123 biopsy-proven cases using an EI/B-mode ratio
of,1.0 as benign and$1.0 as malignant had a sensitivity
of 100% and a specificity of 99% in distinguishing benign
from malignant breast lesions. A large multi-center, un-
blinded trial evaluating 635 biopsy proven cases using
Barr’s criteria had a sensitivity of 99% and a specificity
of 87% (Barr, Destounis et al. 2012). A single center trial
of 230 lesions showed a 99% sensitivity, 91.5% specificity,
PPVof 90% and a NPVof 99.2% using the EI/B-mode ra-
tio (Destounis, Arieno et al. 2013). The EI/B-mode ratio
has been shown to be highly significant between tumor
grades of invasive ductal cancers, with the EI/B-mode ratio
increasing with tumor grade (Grajo 2013).
Either the lesion length ratio or a lesion area ratio
can be used. The lesion is measured in the same position
on both the elastogram and B-mode image. The use of a
mirror function/copy function is helpful in the measure-
ment technique. Difficulty can occur when measuring
the lesion on the elastogram when a fibroadenoma or
fibrocystic lesion arises in dense breast tissue. The strain
properties of the lesion are similar to the background
dense breast tissue. Therefore, one may visualize the
combination of the lesion and normal dense breast tissue
as one lesion, creating a false positive (Barr 2012). This
problem can be avoided by comparing the stiffness of
the lesion to surrounding tissue; if it is similar to fibro-
glandular tissue, it is most likely benign. Using the color
scale or LFR may help eliminate this problem. Strain
images obtained using the ARFI technique can be inter-
preted using this technique.n screening ultrasound. The Hitachi-Aloka SE image is on
t. Regions of interested have been placed in the tumor and
R or Strain Ratio). The Strain Ratiowas 14.57 in this case
e ductal carcinoma (pT1b, pN0, Luminal A type) on core
psy.
Figure 4. A 55-year-old woman, who presented with a speculated mass on screening mammography. A speculated mass
(max length 10 mm) was detected on ultrasound B mode image. The diagnosis was invasive ductal carcinoma (pT2, pN0,
Luminal A type) on using core needle biopsy. The Hitachi-Aloka SE image is on the center of the imagewhile the B-mode
image is on the right and the pathological image is on the left. The SE’s stiff area (blue area) is very similar to the cancer on
gross pathology (white area) and is larger than the mass depicted on the B-mode.
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This diagnostic approach was advocated by Ueno
et al. (Ueno E 2007) as a semi-quantitative method of
evaluating stiffness. As shown in Figure 3, it is the ratio
of the strain in a mass to the strain in subcutaneous fat,
and it is a semi-quantitative method for evaluating how
much stiffer a mass is compared with fat. The tumor
ROI should be placed entirely in the tumor in B-mode.
The target ROI for subcutaneous fat should be limited
to fat that does not contain fibroglandular breast tissue
at a similar depth to the lesion.
Because this method allows evaluation of the stiff-
ness of one specific region of a mass by positioning the
ROI, not only is it possible to measure very large tumors,
it is also possible to evaluate the stiffness of non-mass
abnormalities. This easy to apply approach provides an
approximation of tumor stiffness.
Farrokh et al. (Farrokh, Wojcinski et al. 2011) re-
ported a sensitivity of 94.4% and specificity of 87.3%
with a cut-off above 2.9 in a prospective study using
the strain ratio (FLR). In a study using B-mode, strain
pattern (elasticity score), width ratio, and strain ratio,
Alhabshi et al. (Alhabshi, Rahmat et al. 2013) reported
that width ratio and strain ratio were the most useful
methods of lesion characterization, with a cut-off value
of 1.1 for width ratio and a cut-off value of 5.6 for strain
ratio. Stachs et al. (Stachs, Hartmann et al. 2013)
demonstrated the FLR utility in 224 breast masses in
215 patients that the strain ratio was predominantly
higher in malignant tumors, i.e., 3.04 6 0.9 (Mean 6
SD) for malignant tumors versus 1.91 6 0.75 for benign
tumors. In a meta-analysis of 2,087 lesions, Sadigh (Sa-
digh, Carlos et al. 2012) found an overall sensitivity of
88% and specificity of 83% when using strain ratio. Us-
ing the length ratio his data showed a sensitivity of 98%
and a specificity of 72%.
Estimation of pathological features (diagnosis of
non-mass abnormalities and differentiation of patholog-
ical features).Many clinicians think SE reflects patholog-
ical features relatively well, and there have been manyreports of comparisons with resected specimens. A min-
imal breast cancer elastography image, a macroscopic
image of the resected specimen, and an image of hema-
toxylin and eosin staining are shown in Figure 4. The stiff
part (blue) on elastography corresponds to the spread of
breast cancer in the radial direction.
In addition, SE subtly depicts not only stiff regions
(with little strain) but also soft regions (with much strain),
greatly increasing the diagnostic range of ultrasound.
Breast-conserving surgery is the mainstay of breast
cancer surgery, but the common widespread intraductal
component makes assessment of the extent of resection
important. Using elastography to determine tumor spread
before breast-conserving surgery, Nakashima et al.
(Nakashima and Moriya 2012) reported that it was
effective for evaluation of the intraductal component.
As elastography was useful for assessing the intraductal
component, which is similar to a non-mass abnormality,
elastography may also be useful for non-mass abnormal-
ities. Color changes on the elastography of an intraductal
component are useful for predicting the pathological fea-
tures of intraductal progression.
Adamietz et al. (Adamietz, Kahmann et al. 2011)
reported that elastography color patterns were useful
for comparing and differentiating phyllodes tumors and
fibroadenomas.
Recommended imaging techniques. SE supports ‘‘no
manual compression,’’ ‘‘minimal vibration,’’ and ‘‘signif-
icant compression.’’ It is certainly possible to diagnosis
many masses using the ‘‘significant compression’’ ap-
proach to elastography, but it is impossible to acquire
elastography images in the case of minute lesions such
as intraductal lesions using this approach. Therefore,
‘‘minimal vibration’’ is recommended for elastography
imaging of minute lesions. In the case of deep lesions,
however, ‘‘significant compression’’ may be better for
acquiring an adequate elastography image, as the other
approaches might not provide sufficient vibration energy.
For beginners, it may be useful to refer to a strain
graph that shows in real time the changes in strain over
1154 Ultrasound in Medicine and Biology Volume 41, Number 5, 2015time to assist deploying these techniques, but experts can
usually assess accuracy using the images.
 Displayed Range of Interest (ROI)
Various color or gray scale maps can be used in SE
as well as grey scale. To avoid confusion, the scale should
always be included in images or discussions. The scale is
relative and is based on the range of tissue stiffness in the
image. The ROI should partly include subcutaneous tis-
sue and the pectoralis muscle for a more consistent scale
range, and it should be expanded to its maximal width to
express relative values more accurately. Ribs and lungs
should not be included (Barr 2012). In most systems,
the color-coding is post processing and the color maps
can be changed after acquisition. Imaging time
In SE, the color-coding is visualized immediately
after the initial vibration (approximately 1 sec), but imag-
ing needs to continue until the color of the entire target is
completely stable in order to acquire reliable results.
The amount of time required will shorten as your
skill improves, so it is recommended that you startFigure 5. (A) Simple cyst in a 39-year-old woman who presen
and the elastogram on the right. The elastogram shows the cha
with a central bright spot (green arrow) and posterior bright spo
nent (blue arrow) and the cystic area (red arrow) can be identifie
demonstrated a 2-mm benign papilloma. Courtesy of Car
(Figures with permission from Ultrasoundby taking plenty of time and continue until the color is
stable.
Images and pathological features. The most useful
point to remember in everyday practice is that informa-
tion that can be used to determine benignity without
cytology or biopsy can be acquired by differentiating im-
ages of cysts, fibroadenomas, and fat islands in patients
recalled for closer examination. Elastography also in-
creases confidence that a stiff lesion is a malignancy.
Representative images that illustrate the usefulness of
elastography for diagnosis are provided elsewhere (see
WFUMB website).
 Cystic lesions
There are characteristic SE patterns that can charac-
terize a lesion as cystic.
 Bull’s Eye Artifact
A characteristic elastogram, the Bull’s Eye Artifact,
is observed with benign simple and complicated cysts
with some systems (Barr and Lackey 2011). This artifact
is characterized by a white central signal within a black
outer ring and a bright spot posterior to the lesion. Itts with a palpable mass. The B-mode image is on the left
racteristic ‘‘Bull’s Eye’’ artifact, a black area (red arrow)
t (blue arrow). (B) In this complex mass, the solid compo-
d in the elastogram. A core biopsy of the solid component
mel Smith, Queensland Imaging, Brisbane Australia.
Quarterly (Barr and Lackey 2011)).
Figure 6. A 45-year-old woman presented with a 10-mm mass on ultrasound screening. On the Hitachi system, the cyst
has the BGR artifact, suggesting it is a benign cyst. Diagnosis confirmed by fine needle aspiration cytology.
WFUMB Guidelines for Ultrasound Elastography - Breast d R. G. BARR et al. 1155results from the movement of fluid which causes de-
correlation between images (Barr and Lackey 2011)
(Figure 5). In a monocentric study, this artifact had a
high predictive value for the lesion being a benign cyst.
Any solid component in the cyst appears as a solid lesion
within the pattern (Figure 5b). Although limited casesFigure 7. Upper: A 50-year-old woman with an abnormality in
her left breast on screening mammography. The upper image is
the color-coded SWE image and the B-mode image is below the
SWE image. The mass had a high shear wave speed (153 kPa)
color-coding red. On biopsy, the lesion was an invasive ductal
carcinoma (pT1a, pN0). Lower: A 48-year-old woman who pre-
sented with an abnormality in her left breast on screening ultra-
sound. The mass color-coded blue, having a low shear wave
speed (8.7 kPa). On biopsy, the lesion was a fibroadenoma.have been reported, this artifact is not observed in
mucinous or colloid cancers (Barr and Lackey 2011).
The artifact can be used to decrease the number of bi-
opsies performed (Barr and Lackey 2011). In one series,
10% of solid lesions on B-mode were in fact complicated
cysts (Barr and Lackey 2011). This useful artifact is
observed with some equipment (Siemens and Philips)
but may not be observed with other equipment.
 BGR sign
In the case of strain imaging with other vendors’ sys-
tems, a red band is visualized in the deep part of a lesion
that is nearly anechoic. This unique pattern appears when
there are no echoes in the mass and increased strain
directly deep to it, and it is thought to indicate that the in-
side of the mass is liquid. It presents as blue, green, and
red layers beginning in the shallow area, which is referred
to as the BGR sign (Figure 6).
Limitations. Accuracy differs between shallow sites
and deep sites due to problems associated with propaga-
tion of vibration energy. Further improvement of applica-
tions and adjustments to imaging methods are needed.
Reports on the strain ratio have used different cut-off
values, so a multicenter study that includes accuracy con-
trol is needed.
Summary. There is significant evidence that SE has
high sensitivity and specificity for differentiating benign
from malignant masses and for non-mass abnormalities.
Various methods of interpretation (5 point color scale,
length ratio, and lesion to fat ratio) have all been shown
to be effective. Currently, there is not enough evidence
to suggest that one technique is superior to another.SWS measurement and imaging
Introduction. With SWE, a quantitative measure of
the lesion stiffness can be obtained either in a small fixed
ROI (single measurement) or pixel by pixel in a Field-of-
View (FOV) box giving a color map. The results are usu-
ally coded with red as stiff and blue as soft. The technique
1156 Ultrasound in Medicine and Biology Volume 41, Number 5, 2015using SE also pertains to SWE, and pre-compression
should be avoided.
Recommendations; see strain section
Classification; see strain section
Procedures; see strain section
Results. Based on a recent large multi-center study
(BE1) using 2D SWE, a cut-off value of 80 kPa (5.2
m/s) was determined to distinguish BI-RADS category
3 and BI-RADS category 4a lesions with better specificity
(Berg, Cosgrove et al. 2012). Examples are presented in
Figure 7. Tissue measurements in an ROI can be dis-
played in speed (m/s) or in pressure/elasticity (kPa).
The measurement of stiffness should be obtained from
the area of highest stiffness within the lesion or the
surrounding tissue. This large multi-center trial demon-
strated that when SWS is added to BIRADS classification
in B-mode imaging diagnostic accuracy increases (Berg,
Cosgrove et al. 2012). The evaluation of SWE signal ho-
mogeneity and lesion to fat ratios were the best differen-
tiators of benign and malignant. The addition of SWE
increased the characterization of lesion over BI-RADS
alone, with a sensitivity and specificity of 93.1% and
59.4% for BI-RADS and 92.1% and 76.4% with the addi-
tion of SWE. The authors note that the major value of the
addition of SWE is in BI-RADS 3 and 4a lesions where
the SWI results are used to upgrade or downgrade the
lesion (Berg, Cosgrove et al. 2012, Schaefer 2013). The
same study included an analysis of reproducibility, which
was very high (Cosgrove, Berg et al. 2012).
The BE1 rules can be summarized as
1. Any of the features analyzed in SWE could improve
the diagnostic performance (AUCs) of the BI-RADS
score. Thus, SWE features should be combined with
B Mode features, and should not be used alone.
2. The best performing SWE features were the quantified
maximum stiffness of the lesions (inside or on the
periphery), as E Max measurement (Q Box) or visual
color assessment (5-level color scale).
3. The publication suggested aggressive and conserva-
tive rules (i.e., using different stiffness thresholds) to
help assess the level of suspicion of the breast masses,
depending on their initial BI-RADS score. In the stud-
ied population:
A. All BI-RADS 3 masses with high stiffness (E Max
. 160 kPa (7.3 m/s) or E Color 5 Red with SWE
scale set at 180 kPa (7.7 m/s)) could have been up-
graded to biopsy. This would have enabled the early
management of 4 breast cancers.
B. BI-RADS 4a masses with low stiffness could have
been downgraded to follow-up. This would have
increased the specificity and PPV for biopsy of the
ultrasound diagnosis.a. Aggressive rule: low stiffness would be considered
with E Max below 80 kPa (5.2 m/s) or E Color light
blue or below with SWE scale set at 180 kPa (7.7 m/s).
b. Conservative rule: low stiffness would be considered
with E Max below 30 kPa (3.2 m/s) or E Color dark
blue or below with SWE scale set at 180 kPa (7.7 m/s).
c. The aggressive rule would have enabled a higher
improvement in specificity; however, 4 cancers would
have been downgraded to follow-up. With the conser-
vative rule, all cancers would have remained in the
initial biopsy group, while retaining a significant in-
crease in specificity (Schaefer 2013).
In a study of 158 consecutive patients, Chang
(Chang, Moon et al. 2011) found that the mean elasticity
values were significantly higher in malignant masses
(153 kPa 1/- 58) than benign masses (46kPa 1/-43)
(P,0.0001). They determined an optimal cut-off value
of 80 kPa (5.2 m/s) which resulted in a sensitivity and
specificity of 88.8% and 84.9%, respectively. The area
under the ROC curve was 0.898 for conventional US;
0.932 for SWE; and 0.982 for the combined data. In a
study of 48 breast lesions, Athanasiou (Athanasiou,
Tardivon et al. 2010) found similar results with similar
stiffness values for benign lesions (45 1/- 41 kPa) and
malignant lesions (147 kPa 1/- 40)(P,0.001). Their
results suggest that the addition of SWE to conventional
ultrasound could be used to decrease the number of bi-
opsies performed in benign lesions. In a small series
Evans (Evans,Whelehan et al. 2010) found the sensitivity
and specificity for SWE (97% and 83%) to be better than
B-mode alone (87% to 78%). In their series, they used a
cutoff value of 50 kPa (4.1 m/s). They also confirmed that
the technique is highly reproducible.
Quantitative pSWE with ARFI can be used for char-
acterizing breast masses. In a series of 161 masses,
including 43 malignancies, using a SWS cut-off of 3.6
m/s (38 kPa), a sensitivity of 91% and a specificity of
80.6% were achieved (Tozaki, Isobe et al. 2012)
3-D shear wave elastography is in development
(Youk, Gweon et al. 2012, Lee, Chang et al. 2013) and
no recommendations can be made at this time.
Limitations. When using pSWE (Virtual Touch
QuantificationTM (VTq) (Siemens Ultrasound)), where a
single measurement is obtained from a small ROI, it is
not possible to determine where the area of highest
stiffness is located on the B-mode image. Multiple mea-
surements within the lesion and surrounding tissue need
to be obtained to acquire optimal measurements. The
measurement within the tumor often results in ‘‘x.xx’’
signifying that an adequate shear wave for evaluation
was not obtained (Barr 2012). Bai (Bai, Du et al. 2012)
reported that if a lesion is solid and x.xx is obtained the
lesion is most likely a malignancy. With this assumption,
WFUMB Guidelines for Ultrasound Elastography - Breast d R. G. BARR et al. 1157they obtained a sensitivity and specificity of 63.4% and
100%.
Shear waves do not propagate in low viscosity liq-
uids; therefore, simple cysts will not be color-coded.
Shear waves are detected using ultrasonic echo signals.
Therefore, shear waves cannot be detected in areas with
extremely low B-mode signals (anechoic). These regions
appear void of signal and are not color-coded. Examples
are shadowing from ribs or tumors with significant shad-
owing (Barr 2012).
Quality Factor. In very stiff lesions such as invasive
cancers, shear waves may not propagate so that no results
are obtained. The area with no results is not color-coded
(Barr 2012) and interpretation is not possible. In general,
however, the desmoplastic reaction surrounding the tu-
mor will be stiff and appear as a stiff (red) halo surround-
ing the lesion. Even if the entire mass is not coded as stiff,
heterogeneity of the SWE is part of the criteria for a sus-
picious lesion. Pre-compression must be avoided as this
can create the same appearance in a benign lesion (Barr
and Zhang 2012).
In a large number of malignant lesions, the area
identified on B-mode as the hypoechoic mass does not
code on SWE because a shear wave is not identified or4
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Figure 8. A 57-year-old woman presented with a palpable mass
in her right breast. Mammographic and sonographic workup in-
dicates a BI-RADS 4b lesion that proved to be a poorly differ-
entiated invasive ductal cancer on biopsy. The cancer is the
hypoechoic mass in the deeper portion of the image. Two wave-
forms were obtained using the acoustic radiation force impulse
technique, one in the tumor and one in the peri-tumoral area.
The one taken deeper is from the cancer. The more superficial
one is taken in the peritumoral area. The waveform from the
cancer is all noise and not interpretable. The waveform in the
adjacent peri-tumoral tissue has more noise than in the fat sig-
nals but is still interpretable and provides a shear wave speed
(with permission from JUM (Barr 2012)).may code with a low cs. Bai found that 63% of breast ma-
lignancies have this finding (Bai, Du et al. 2012). Prelim-
inary evaluation of this phenomenon suggests that shear
waves may not propagate as expected in some cancers
(Barr 2012) (Figure 8). The shear waves in these tumors
demonstrate significant noise that may be incorrectly
interpreted as a low SWS by the system. The addition
of a quality measure that evaluates the shear waves gener-
ated and determines if they are adequate for an accurate cs
measurement will help in eliminating possible false nega-
tive cases (Barr 2014, Barr 2012) (Figure 9).RECOMMENDATIONS
Should Elastography be performed/interpreted without
B-mode?
Elastography is a complimentary technique to
B-mode imaging. Elastography (SE or SWE) should be
performed and interpreted along with standard B-mode
imaging.Figure 9. Shear wave elastogram (SWE) of a biopsy proven
invasive ductal cancer in a 64-year-old female presenting with
a palpable mass. The velocity map in the upper image shows
a maximum shear wave speed of 3.27 m/s, suggesting a benign
lesion. However, in the Quality Map below, the mass is yellow
and red, indicating that the shear waves are not adequate for
interpretation. Without the quality map, the lesion could have
been classified as a false negative. (Courtesy of Richard G.
Barr MD, PhD).
Table 2. Summary of the interpretation methods and their relationships based on a BI-RADS classification system (along the
bottom of the table). EI/B - Ratio of the lesion size on elastography to the B-mode size. Strain ratio (fat-lesion ratio
(FLR)) - Ratio of target mass stiffness to that of subcutaneous fat (Semi-quantitative value derived from strain elastography
(SE)). Vs - Shear wave velocity or shear wave speed (SWS) in units of m/s and stiffness or elasticity in units of kPa are
quantitative values in Shear Wave Elastography (SWE) systems.
1 2 3 4 5 C1 C2
Hard
Soft
Soft
Soft
Hard
Hard
El/B
<1
El/B
=1
El/B
>1
Strain
Ratio
<2.8
Vs
<2.6m/s
or 20kPa
>2.6m/s
and <4.5m/s
or >20kPa
and <60kPa
>4.5m/s
and <5.2m/s
or >60kPa
and <80kPa
Vs
>5.2m/s
or 80kPa
Strain
Ratio
>2.8, <4.5
Strain
Ratio
>4.5
1158 Ultrasound in Medicine and Biology Volume 41, Number 5, 2015Should one perform SE or SWE imaging?
Both Strain and SWE have been shown to improve
characterization of breast masses. There have been no
comparative studies to suggest one technique is better
than the other.How many techniques should be performed on each
patient?
No studies have been performed to confirm that one
technique is better than the other. Performing more than
one technique on a patient may improve confidence in
the findings.Should a benign elastography downgrade a BIRADS 4b,
4c, or 5 lesion to BIRADS 2 or 3?
Downgrading B3 or B4A is reasonable, but down-
grading a B4b, B4c, or B5 is not recommended. If a B3
lesion has characteristics of a malignancy on strain orSWE, the lesion should be upgraded to a biopsy. If
B-mode or another imaging technique is diagnostic of a
B2 (e.g., fat necrosis), elastography should not be used
to upgrade a lesion.
Should the Bull’s Eye artifact (or BGR Sign) be used to
cancel breast biopsies?
The Bull’s Eye artifact (seen only with certain strain
equipment) has been demonstrated to be highly specific
for benign cystic lesions. It is recommended that the ac-
curacy of the finding first be confirmed in the lab before
biopsies are cancelled. The BGR artifact (seen with
certain equipment) is most likely equivalent to the Bull’s
Eye artifact, but this has not been biopsy proven.
When should elastography (SE or SWE) be performed?
Elastography should be used to characterize an ab-
normality identified on conventional B-mode imaging.
WFUMB Guidelines for Ultrasound Elastography - Breast d R. G. BARR et al. 1159Are there situations when elastography should not be
used?
Elastography (SE or SWE) should not be used when
a lesion is very superficial (,3 mm) from the skin sur-
face. SE should not be used if the lesion is larger than
the FOV box.
What are the limitations of elastography in breast
imaging?
In addition to those listed above, occasionally a ma-
lignant breast lesion may appear soft in shear wave elas-
tography (blue, low shear wave speed (SWS)). In these
situations, it is important to look at the tissue surrounding
the lesion to identify the stiffest part of the lesion. The
heterogeneity or increased SWS in surrounding tissues
is relevant information and will help characterize the
lesion as malignant.
CONCLUSION
There are several methods to obtain and interpret
elastography of the breast. No comparative studies have
been performed to suggest that one method is better
than another.
Table 2 summarizes the various methods of interpretation
and how they are related based on a BI-RADS classifica-
tion system. Elastography systems and the applications
themselves continue to evolve, and new tools and new ev-
idence will likely emerge.We anticipate that the direction
of development, imaging methods, and diagnostic ap-
proaches will change and fragment in the future.
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